Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one edited allele after 1 or 2 doses, respectively, exceeding the anticipated curative threshold Evidence in NHP that T cell directed lipid nanoparticles (LNP) produced […]

âˆ' First patient with facioscapulohumeral muscular dystrophy (FSHD) dosed with Restem-L umbilical lining modified progenitor cells (UMPCs) âˆ' The Phase 1/2a study will evaluate the safety and preliminary efficacy of Restem-L in patients with FSHD âˆ' Clinical study is funded by SOLVE FSHD MIAMI and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — RESTEM

(PinkSheets:ARVLF), BROOKLYN, N.Y., Dec. 08, 2025 (GLOBE NEWSWIRE) — The Rosen Law Firm, P.A. announces that the United States District Court for the Eastern District of New York has approved the following announcement of a proposed class action settlement that would benefit purchasers of securities of Arrival SA and/or CIIG Merger Corp. (OTCMKTS: ARVLF): SUMMARY

(Euronext Amsterdam:ASML),(NASDAQ:ASML), ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average price Total repurchased value 01-Dec-25 39,527 EUR915.08 EUR36,170,185 02-Dec-25 38,518 EUR939.05 EUR36,170,216 03-Dec-25 37,709 EUR959.19 EUR36,169,986 04-Dec-25 37,502 EUR964.47

Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron GlobeNewswire December 08, 2025 Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight loss up to

Rehab 4 Addiction CEO Releases New Article Sharing Effective Tips for Going Sober This December, And Actually Enjoying It GlobeNewswire December 08, 2025 London, England, Dec. 08, 2025 (GLOBE NEWSWIRE) — Rehab 4 Addiction, a leading treatment and alcohol home detox advisory service, is happy to announce the release of its new article, “The Most

Wicked Reserve Dispensary Expands Range with New Refrigerated THC Beverage Section GlobeNewswire December 08, 2025 Rochester, NY, Dec. 08, 2025 (GLOBE NEWSWIRE) — Wicked Reserve Dispensary, a premier cannabis dispensary that has recently opened its doors in downtown Rochester, New York, is excited to announce that it has expanded its range with a new refrigerated

John Galt Solutions positioned as a Leader in the SPARK Matrix(TM): Supply Chain Planning, Q4 2025 by QKS Group GlobeNewswire December 08, 2025 Pune, India, Dec. 08, 2025 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading SCP vendors. John Galt Solutions, with its Supply Chain Planning platform

HealthLynked Appoints Duncan McGillivray as Chief Operating Officer to Accelerate National Expansion and Nasdaq Uplisting Strategy GlobeNewswire December 08, 2025 NAPLES, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) — via IBN — HealthLynked Corp. (OTCQB: HLYK), the nation's leading patient-centric healthcare networking platform, today announced the appointment of Duncan McGillivray, MBA, as its new Chief Operating

HyOrc Secures 10-Year Offtake Commitment for Green Methanol Pilot; Global Energy Players Show Investment Interest In Expansion GlobeNewswire December 08, 2025 HOUSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) — HyOrc Corporation (OTC: HYOR), a fully SEC-reporting clean-energy company focused on decarbonizing heavy industry, today announced a significant commercial milestone for its Portuguese green methanol project, reinforcing